RenovoRx (RNXT) Inventory Average (2025 - 2026)

RenovoRx (RNXT) posted Inventory Average of $284000.0 for Q1 2026, up 23.21% sequentially from $230500.0 in Q4 2025.

RenovoRx (RNXT) Inventory Average (2025 - 2026) Analysis & Trends

RenovoRx has reported Inventory Average for 2 years, with the latest figure at $284000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	140.22 Bn	132.37 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	86.29 Bn	78.30 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	65.17 Bn	59.98 Bn	1.37 Bn	-
4	Moderna	61.38 Bn	56.24 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	42.18 Bn	37.09 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	30.99 Bn	27.68 Bn	992.69 Mn	90.57 Mn
7	BioNTech SE	28.45 Bn	10.05 Bn	668.28 Mn	196.36 Mn
8	Insmed	27.47 Bn	26.31 Bn	358.27 Mn	137.65 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	RenovoRx	59.83 Mn	59.83 Mn	766,000.00	381,000.00

Download Data